Roni Diaz

Roni Diaz currently serves as the Vice President of Clinical & Regulatory Affairs at Salvia BioElectronics, a position held since April 2025. Prior experience includes holding the same title at BlueWind Medical, where significant achievements included leading the FDA de novo submission and CE Mark approval for the Revi neuromodulation system. Roni’s tenure also covers roles such as Director of Global Clinical Affairs at INSIGHTEC, where clinical strategy was directed for focused ultrasound technology, and Director of Clinical Studies at Abbott, overseeing feasibility and post-approval studies for Class III neuromodulation devices. Earlier professional experience includes roles in regulatory affairs and clinical project management at Retractable Technologies, MedTrials, Inc., and ArthroCare Corporation. Roni holds a Bachelor of Science degree in Health Science from San José State University.